StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
FibroGen (FGEN) halted, news pending
November 8, 2019 1:56 PM
FibroGen (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trading Halts
Next Articles
FibroGen (FGEN) Reports Positive Phase 3 Pooled Roxadustat Safety & Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
November 8, 2019 3:00 PM
FibroGen (FGEN) to Resume Trading at 2:30 pm
November 8, 2019 2:12 PM